Fate Therapeutics
FATE
FATE
40 hedge funds and large institutions have $60.8M invested in Fate Therapeutics in 2016 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 10 increasing their positions, 13 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
40
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$15.1M | |
| 2 | +$1.84M | |
| 3 | +$1.78M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$93.9K |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$92K |
Top Sellers
| 1 | -$780K | |
| 2 | -$451K | |
| 3 | -$240K | |
| 4 |
EA
Emerald Acquisition
Seattle,
Washington
|
-$184K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$169K |